News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Sierra Oncology
Sierra Oncology Announces Submission of New Drug Application for Momelotinib to US Food & Drug Administration
June 17, 2022
From
Sierra Oncology
Via
Business Wire
Tickers
SRRA
Momelotinib Pivotal Phase 3 Data Receives Oral Presentation at American Society of Clinical Oncology Annual Meeting
May 26, 2022
From
Sierra Oncology
Via
Business Wire
Tickers
SRRA
Sierra Oncology Announces Oral Presentation of Momelotinib Pivotal Phase 3 Data at European Hematology Association Annual Meeting
May 12, 2022
From
Sierra Oncology
Via
Business Wire
Tickers
SRRA
Sierra Oncology Reports First Quarter 2022 Results
May 06, 2022
From
Sierra Oncology
Via
Business Wire
Tickers
SRRA
Sierra Oncology Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
May 05, 2022
From
Sierra Oncology
Via
Business Wire
Tickers
SRRA
GSK Reaches Agreement to Acquire Late-Stage Biopharmaceutical Company Sierra Oncology For $1.9bn
April 13, 2022
From
Sierra Oncology
Via
Business Wire
Tickers
SRRA
Sierra Oncology Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
April 06, 2022
From
Sierra Oncology
Via
Business Wire
Tickers
SRRA
Sierra Oncology Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
February 18, 2022
From
Sierra Oncology
Via
Business Wire
Tickers
SRRA
Sierra Oncology Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
February 04, 2022
From
Sierra Oncology
Via
Business Wire
Tickers
SRRA
Sierra Oncology Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
February 03, 2022
From
Sierra Oncology
Via
Business Wire
Tickers
SRRA
Sierra Oncology to Participate in Guggenheim Oncology Conference
February 03, 2022
From
Sierra Oncology
Via
Business Wire
Tickers
SRRA
Sierra Oncology Announces Closing of Upsized Public Offering of $135.0 Million of Securities
January 31, 2022
From
Sierra Oncology
Via
Business Wire
Tickers
SRRA
Sierra Oncology to Present at B. Riley Securities Oncology Investor Conference
January 27, 2022
From
Sierra Oncology
Via
Business Wire
Tickers
SRRA
Sierra Oncology Announces Pricing of Upsized Public Offering of Securities
January 26, 2022
From
Sierra Oncology
Via
Business Wire
Tickers
SRRA
Sierra Oncology Announces Proposed Public Offering of Common Stock
January 25, 2022
From
Sierra Oncology
Via
Business Wire
Tickers
SRRA
Sierra Oncology Provides Financial Update to Support the Future Commercialization of Momelotinib
January 25, 2022
From
Sierra Oncology
Via
Business Wire
Tickers
SRRA
Sierra Oncology Announces Momelotinib Achieved Statistically Significant Benefit on Symptoms, Anemia and Splenic Size in the Pivotal MOMENTUM Study for Myelofibrosis
January 25, 2022
From
Sierra Oncology
Via
Business Wire
Tickers
SRRA
Momelotinib Review Article Published in Journal of Hematology & Oncology Highlights Importance of Anemia Benefit for Myelofibrosis Patients
January 19, 2022
From
Sierra Oncology
Via
Business Wire
Tickers
SRRA
Sierra Oncology Updates Topline Data Timing for Pivotal Phase 3 Trial of Momelotinib in Myelofibrosis
January 18, 2022
From
Sierra Oncology
Via
Business Wire
Tickers
SRRA
Sierra Oncology Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
January 07, 2022
From
Sierra Oncology
Via
Business Wire
Tickers
SRRA
Sierra Oncology Reports Baseline Ferritin Differentially Predicts Week 24 Transfusion Independence Response in Myelofibrosis Patients
December 13, 2021
From
Sierra Oncology
Via
Business Wire
Tickers
SRRA
Sierra Oncology Announces Investor Event to Review MOMENTUM Trial Design and Available Phase 3 Momelotinib Data in Myelofibrosis
December 06, 2021
From
Sierra Oncology
Via
Business Wire
Tickers
SRRA
Sierra Oncology Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
December 03, 2021
From
Sierra Oncology
Via
Business Wire
Tickers
SRRA
Sierra Oncology Announces Presentation at Jefferies London Healthcare Conference
November 12, 2021
From
Sierra Oncology
Via
Business Wire
Tickers
SRRA
Sierra Oncology Reports Third Quarter 2021 Results
November 05, 2021
From
Sierra Oncology
Via
Business Wire
Tickers
SRRA
Sierra Oncology Announces Momelotinib Poster Accepted for Presentation at ASH
November 04, 2021
From
Sierra Oncology
Via
Business Wire
Tickers
SRRA
Sierra Oncology Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
November 03, 2021
From
Sierra Oncology
Via
Business Wire
Tickers
SRRA
Sierra Oncology Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
October 04, 2021
From
Sierra Oncology
Via
Business Wire
Tickers
SRRA
Sierra Oncology to Present at Three September Investor Conferences
September 07, 2021
From
Sierra Oncology
Via
Business Wire
Tickers
SRRA
Sierra Oncology Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
September 03, 2021
From
Sierra Oncology
Via
Business Wire
Tickers
SRRA
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.